Disulfide-stapled helical hairpin peptide selectively traps cancer-driving TAZ protein with potent anti-tumor activity | Research

The takeaway

A rationally designed, disulfide-stapled 25-mer peptide (TAZ-hTrap) derived from TEAD protein selectively binds TAZ with high affinity through entropy minimization, showing potent cytotoxicity against diverse gynecological tumors.

Undruggable target drugged
A disulfide-stapled helical hairpin peptide selectively traps TAZ—an "undruggable" cancer driver—with potent activity against gynecological tumors

What the researchers found

25-mer stapled helical hairpin from TEAD. Disulfide bridge stabilizes native conformation. Minimized entropy penalty → improved TAZ binding. Selective for TAZ over noncognate proteins. Potent cytotoxicity on gynecological tumors (cervical, ovarian, endometrial). Confirmed by CD, FP, and viability assays.

Why it matters

The Hippo/TAZ pathway drives multiple gynecological cancers but has been considered "undruggable." This stapled peptide demonstrates that protein-protein interactions can be disrupted by rationally designed peptide traps.

How the study worked

Rational peptide design from TEAD protein structure. Molecular dynamics and energetics simulation. Disulfide stapling. Circular dichroism (CD). Fluorescence polarization (FP). Cell viability assays on gynecological tumor lines.

What this study cannot tell us

In vitro cytotoxicity only. No in vivo tumor models. Pharmacokinetics, stability, and delivery not assessed. Cell viability does not prove in vivo anti-tumor efficacy.

How to read the evidence

In vitro proof of concept with computational, biophysical, and cellular validation. Strong design but needs in vivo data.

When this study was published

Published in 2025.

The bigger picture

Stapled peptides that trap oncoproteins represent a growing therapeutic strategy. TAZ-hTrap demonstrates the helical hairpin trap concept—potentially applicable to other "undruggable" protein-protein interactions in cancer.

Questions still open

Does TAZ-hTrap show anti-tumor efficacy in xenograft models?
Could this helical hairpin trap approach target other undruggable oncoproteins?
What delivery method would enable clinical use?

Common questions

What is a stapled peptide trap?

It is a short protein fragment (peptide) that mimics part of a natural protein interaction, locked into its active shape by a chemical "staple" (here, a disulfide bridge). TAZ-hTrap mimics how the TEAD protein grabs the cancer-driving TAZ protein, essentially trapping TAZ and preventing it from activating cancer genes.

Why is TAZ important in cancer?

TAZ is a key driver of the Hippo signaling pathway that controls cell growth. When dysregulated, it promotes cancer development in gynecological organs (cervix, ovaries, uterus). It has been considered "undruggable" because it works through protein-protein interactions that are hard to block with traditional small molecule drugs.

Read the original research

TAZ-hTrap: A Rationally Designed, Disulfide-Stapled Tead Helical Hairpin Trap to Selectively Capture Hippo Signaling Taz With Potent Antigynecological Tumor Activity.

Journal of molecular recognition : JMR, 38(2), e3111

View on PubMed ↗Publisher’s paper ↗

Citation

Tang, Bin; Du, Yu; Wang, Jun. (2025). TAZ-hTrap: A Rationally Designed, Disulfide-Stapled Tead Helical Hairpin Trap to Selectively Capture Hippo Signaling Taz With Potent Antigynecological Tumor Activity.. Journal of molecular recognition : JMR, 38(2), e3111. https://doi.org/10.1002/jmr.3111